MARKAZIY ASAB TIZIMI O‘SMALARI: ZAMONAVIY TAHLIL, KLASSIFIKATSIYA VA INDIVIDUALLASHTIRILGAN DAVOLASH YO‘NALISHLARI

Jasur Saidov; Suhrob O‘rolov

Authors

Saidov Jasur Termez iqtisodiyot va servis universiteti Tibbiyot fakulteti o‘qituvchilari
O‘rolov Suhrob Termez iqtisodiyot va servis universiteti Tibbiyot fakulteti Davolash ishi talabasi

Keywords:

neyroonkologiya, gliomalar, glioblastoma, nishonlovchi terapiya, miya o‘smalari, kimyo terapiyasi, radioterapiya.

Abstract

Markaziy asab tizimi o‘smalari (gliomalar, meningiomalar va ependimomalar) hayot uchun xavfli bo‘lgan, tashxis qo‘yish va davolashda yuqori texnologiyalar talab etadigan kasalliklardir. Ushbu maqolada 72 nafar bemorning klinik tahlillari yosh va jins bo‘yicha chuqur o‘rganilgan. Gistologik turlar, davolash strategiyalari va ularning natijalari, shu jumladan, glioblastomada targetlangan terapiya samaradorligi muhokama qilingan. Hosil qilingan natijalar zamonaviy tashxis va davolash usullarini rivojlantirishga yo‘naltirilgan.

References

1. Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., ... & Ellison, D. W. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica, 131(6), 803-820.

2. Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019). CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-Oncology, 21(Suppl_5), v1-v100.

3. Wen, P. Y., & Kesari, S. (2008). Malignant gliomas in adults. The New England Journal of Medicine, 359(5), 492-507.

4. Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., ... & Mirimanoff, R. O. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England Journal of Medicine, 352(10), 987-996.

5. Reardon, D. A., & Wen, P. Y. (2015). Targeted therapies for malignant gliomas: current status and future directions. Oncology, 29(6), 419-429.

6. Hegi, M. E., Diserens, A. C., Gorlia, T., Hamou, M. F., de Tribolet, N., Weller, M., ... & Stupp, R. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. New England Journal of Medicine, 352(10), 997-1003.

7. DeAngelis, L. M. (2001). Brain tumors. New England Journal of Medicine, 344(2), 114-123.

8. Walker, M. D., Alexander, E., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., ... & Wise, G. (1978). Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. Journal of Neurosurgery, 49(3), 333-343.

9. Duffau, H. (2005). Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. The Lancet Neurology, 4(8), 476-486.

10. Batchelor, T. T., & Reardon, D. A. (2009). Treatment of recurrent glioblastoma: current challenges and future approaches. Neuro-Oncology, 11(1), 6-16.

11. Bekmirzayev E.R. i dr. Биохимия жировой ткани //Лучшие интеллектуальные исследования. – 2023. – Т. 10. – №. 3. – С. 88-91.

12. Bekmirzayev E.R. i dr. Витамин А //Лучшие интеллектуальные исследования. – 2023. – Т. 10. – №. 3. – С. 92-94.

13. Bekmirzayev E.R. i dr. Мочевина //Лучшие интеллектуальные исследования. – 2023. – Т. 10. – №. 3. – С. 85-87.